Organigram makes THCV investment in US cannabis genetics company Phylos
Canadian producer Organigram Holdings is investing as much as $8 million in Portland, Oregon-based cannabis genetics and seeds…
News May 26
Latest In: minor cannabinoids
Widespread crackdown on delta-8 THC could pose a threat to other cannabinoids
Delta-8’s meteoric rise in popularity is forcing a conversation about how to regulate minor cannabinoids. Until recently, delta-8…
News February 1
Price and potency drive flower sales, but educated consumers show interest in terpenes and minor cannabinoids
Flower is the undisputed champion of marijuana products, making up more than half of market share - and…
News November 1
Sponsored
The New Genetics Race: Why Cannabis Seed Brands Are Becoming the Next Big Differentiator
As cannabis shoppers become more educated, seed brands are no longer just selling genetics — they are shaping loyalty, discovery, and the next wave of premium cultivation culture.
June 9
MJBizCon speaker highlights dangers of delta-8 THC, touts benefits
The cannabis industry should be concerned about the safety of delta-8 THC, but it might have a place…
News October 20
Minor cannabinoids will likely have a large role in the wellness industry
Move over CBD. Make way for CBN and CBG. Hemp and marijuana executives say the booming wellness market…
News May 1Featured
1
Latest Sponsored
